Dazublys
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Dazublys, covering 2026-04-28 to 2026-04-28. Get the full timeline:
Most recent: EMA Authorised: Dazublys (trastuzumab) — CuraTeQ Biologics s.r.o
1 regulatory and trial event tracked for Dazublys, covering 2026-04-28 to 2026-04-28. Get the full timeline:
Most recent: EMA Authorised: Dazublys (trastuzumab) — CuraTeQ Biologics s.r.o